RecruitingNot ApplicableNCT07301905

Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI

Culturally Targeted Messaging and Parental Receptivity to the Human Papillomavirus Vaccine


Sponsor

Michigan State University

Enrollment

265 participants

Start Date

Nov 17, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if culturally targeted messaging about the human papillomavirus (HPV) increases receptivity to the HPV vaccine among African American parents of vaccine-eligible daughters. The main question it aims to answer is: • Does culturally targeted messaging increase African American parents' intentions to vaccinate their daughter against HPV? Research will compare culturally targeted messaging to general, educational messaging and no messaging. Participants will: * View culturally targeted messages, education-only messages, or no messages about the HPV vaccine * Report their intentions to vaccinate their daughter against HPV * Report whether they have initiated HPV vaccination for their daughter six months later


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Identify as Black/African American or White/Caucasian
  • Have at least one daughter who is between 8-17 years of age, who is not currently pregnant, and who has not received any doses of the HPV vaccine

Exclusion Criteria1

  • N/A

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALGeneral HPV Vaccine Health Messaging

General, education-only messaging about the HPV vaccine does not include culturally targeted messaging.

BEHAVIORALCulturally Targeted HPV Vaccine Health Messaging

Educational messaging about the HPV vaccine includes culturally targeted messaging about the HPV vaccine.


Locations(1)

Flint Journal Building

Flint, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07301905


Related Trials